Who
Robert F. Friel
Director
Company insider
Files Form 4 as: Director, Xylem; Director, West Pharmaceutical Services; Director, Nuvasive; Chairman and CEO, Revvity; Director, Carefusion; Director, Fairchild Semiconductor International; Director, Millennium Pharmaceuticals.
In numbers
- Trades disclosed
- 232
- Buys
- 0
- Sells
- 29
- Bought
- $0
- Sold
- $108.3M
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 7 Feb 2001
- Last trade
- 14 May 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 15 May 2026 | XYL XylemMachinery | SEC FORM 4 Code A | $290K2,481 at $116.88 | filing |
| 14 May 2026filed 15 May 2026 | XYL XylemMachinery | SEC FORM 4 Code A | $290K2,481 at $116.88 | filing |
| 4 May 2026filed 6 May 2026 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 13 May 2025filed 14 May 2025 | XYL XylemMachinery | SEC FORM 4 Code A | $235K1,851 at $126.93 | filing |
| 6 May 2025filed 8 May 2025 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —1,071 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | XYL XylemMachinery | SEC FORM 4 Code A | —1,647 at $0.00 | filing |
| 23 Apr 2024filed 25 Apr 2024 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —564 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —5,113 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —850 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —2,822 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —2,130 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —3,230 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —2,577 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —3,095 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —2,702 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —3,788 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —4,816 at $0.00 | filing |
| 9 Jun 2023filed 12 Jun 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code A | —4,816 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | XYL XylemMachinery | SEC FORM 4 Code A | —2,250 at $0.00 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonRVTY · themarketsdaily.com · 19 Oct 2026Revvity (NYSE:RVTY) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.RVTY · dailypolitical.com · 14 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)RVTY · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Robert F. Friel; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.